Knee Osteoarthritis Study
Knee Osteoarthritis
Not SpecifiedActive - Enrolling
Key Facts
Indication
Knee Osteoarthritis
Phase
Not Specified
Status
Active - Enrolling
Company
About Arizona Research Center
Arizona Research Center is a private, services-oriented clinical research site operating in Phoenix since 2005. It generates revenue by conducting Phase 1-4 clinical trials on behalf of sponsor companies and CROs across multiple therapeutic areas, including orthopedics, cardiovascular, and metabolic diseases. The company actively recruits both patient volunteers and healthy participants, offering compensation, and also seeks to expand its investigator base. Its primary value proposition is providing patient access and reliable clinical trial execution in a key US geographic market.
View full company profileTherapeutic Areas
Other Knee Osteoarthritis Drugs
| Drug | Company | Phase |
|---|---|---|
| Progenza | Cambium Bio | Phase 1/2a |
| MAG200 | Magellan | Phase 3 |
| MUTI™ Knee Replacement | Meril | Commercial |
| DUROLANE | Bioventus | Commercial |
| XSTEM | Xintela | Phase I/IIa |
| Stempeucel® | Stempeutics Research | Commercial |
| Lipogems System for Knee Osteoarthritis | Lipogems International | Phase 3 |
| Signature Cord Prime™ | Arugula Sciences | Phase 1 |
| 4P004 | 4Moving Biotech | Phase 2a |
| Lorecivivint (inferred) | Biosplice Therapeutics | Phase 3 |
| Regenerative Cell Therapy for Osteoarthritis | InGeneron | Phase 3 |
| ArthroCart | Arthro Biotech | Preclinical |